Neurology Minute cover art

All Episodes

Neurology Minute — 115 episodes

#
Title
1

Bridging the Artificial Intelligence Training Gap - Part 1

2

September 2026 President Spotlight: Our Next Step in Brain Health

3

Updates in Neuroinfectious Disease - Part 5

4

Updates in Neuroinfectious Disease - Part 4

5

Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments - Part 1

6

National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care

7

Updates in Neuroinfectious Disease - Part 3

8

Updates in Neuroinfectious Disease - Part 2

9

Updates in Neuroinfectious Disease - Part 1

10

Lab Minute: Vitamin B12

11

American Epilepsy Society Clinical Practice Guideline - Part 2

12

The Relationship Between Age and Recovery After Spinal Cord Injury

13

Virtual vs In-Person Neurologic Ambulatory Care

14

Lab Minute: Tolosa Hunt Syndrome

15

Consortium of Neurology Residents and Fellows

16

Vamorolone for Duchenne Muscular Dystrophy

17

American Epilepsy Society Clinical Practice Guideline - Part 1

18

Post-Traumatic Headache in Children and Genetic Risk of Migraine

19

Efficacy and Safety of Cemdisiran siRNA in Myasthenia Gravis

20

Negative Myoclonus

21

An Update on Troriluzole

22

The Current State of Diagnostics for Neuroimmunologic Disorders in Africa

23

Ampreloxetine for Neurogenic Orthostatic Hypotension in MSA

24

Sex Differences in Levodopa Pharmacokinetics in Early Parkinson Disease

25

Psychiatric Comorbidities in Epilepsy - Part 2

26

August 2026 President Spotlight: How We're Working with the AMA

27

Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2

28

Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1

29

Psychiatric Comorbidities in Epilepsy - Part 1

30

2026 International Conference on Functional Neurological Disorder - Part 2

31

Exploring Military Sexual Trauma and Migraine Among US Veterans - Part 2

32

2026 International Conference on Functional Neurological Disorder - Part 1

33

Exploring Military Sexual Trauma and Migraine Among US Veterans - Part 1

34

Lab Minute: Susac Syndrome and Behçet Disease

35

Lab Minute: Human Prion Disease

36

Lab Minute: Human Prion Disease

37

July 2026 President Spotlight: Mid-Year Update

38

Preparing ALS Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants

39

When Drug Marketing Masquerades as Clinical Trials

40

The DRAIN Trial

41

Diagnosis and Management of Headache

42

Navigating the Transition From Pediatric to Adult Epilepsy Care - Part 2

43

Neurology® at 75: The Evolution of the Neurology Journal

44

Navigating the Transition From Pediatric to Adult Epilepsy Care - Part 1

45

June 22, 2026 Capitol Hill Report: Huge Milestone for Prior Authorization Bill

46

Epilepsy Fundamentals Refresher Series - Part 3

47

Epilepsy Fundamentals Refresher Series - Part 3

48

Epilepsy Fundamentals Refresher Series - Part 2

49

Communication About Uncertainty During PD Diagnostic Consultations

50

Comparing Sensitivity of Nerve Biopsy, Skin Biopsy, and Fat Aspirate in ATTRv-PN

51

Epilepsy Fundamentals Refresher Series - Part 1

52

Low Prevalence and Inconsistency of LRP4-IgG Detection in Suspected MG

53

2026 European Stroke Organization Conference - Part 2

54

2026 European Stroke Organization Conference - Part 1

55

Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD

56

Safety and Efficacy of Adjunct Dexamethasone in Adults with Herpes Simplex Virus Encephalitis in The UK - Part 3

57

The Role of Social Media in Neurology Trainees' Professional Identity Formation - Part 2

58

Neurology Wait Times After Primary Care or Emergency Department Visits - Part 2

59

Neurology Wait Times After Primary Care or Emergency Department Visits - Part 2

60

The Role of Social Media in Neurology Trainees' Professional Identity Formation -Part 1

61

Neurology Wait Times After Primary Care or Emergency Department Visits - Part 1

62

Asundexian and OCEANIC-STROKE: A New Era in Stroke Prevention

63

Acute Kidney Injury Related to Contrast Exposure

64

Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache

65

Comparative Accuracy of TCD, TTE, TEE, and Cardiac CT for Detecting Right-to-Left Shunt in ESUS

66

Miv-cel CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome

67

Miv-cel CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome

68

Understanding Rett Syndrome - Part 4

69

Lab Minute: MTHFR

70

June 2026 President Spotlight: Community at the AAN

71

New Resident Guide to Stroke Alerts - Part 2

72

New Resident Guide to Stroke Alerts - Part 1

73

Understanding Rett Syndrome - Part 3

74

Shunting for Idiopathic Normal Pressure Hydrocephalus

75

Recent Updates in Central Retinal Artery Occlusions

76

Prion Disease Clinical Trial NN112

77

Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 2

78

Understanding Rett Syndrome - Part 2

79

Lower Risk of Dementia with AS01-Adjuvanted Vaccination Against Shingles and Respiratory Syncytial Virus Infections

80

Humoral Vaccine Responses and One-year Follow-up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding - Part 3

81

Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 1

82

Inflammation, Limbic White Matter, and Symptoms After Repetitive Head Impacts in Retired Football Players

83

Understanding Rett Syndrome - Part 1

84

Humoral Vaccine Responses and One-year Follow-up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding - Part 2

85

Humoral Vaccine Responses and One-year Follow-up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding - Part 1

86

Updates Regarding Radiation Necrosis - Part 1

87

Association of Changes in Activity Patterns With Brain Atrophy and Disability Progression in People With MS

88

Clinical Heterogeneity and Candidate Biomarkers in POLG-Related Mitochondrial Disease - Part 2

89

Workplace Lactation in Neurology: Barriers and Opportunities - Part 2

90

May 2026 President Spotlight: AAN Annual Meeting Update

91

Clinical Heterogeneity and Candidate Biomarkers in POLG-Related Mitochondrial Disease - Part 1

92

Workplace Lactation in Neurology: Barriers and Opportunities - Part 1

93

Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 3

94

Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 2

95

Epstein-Barr Virus Antibodies to Differentiate MS From Other Neuroinflammatory Diseases - Part 2

96

Clinical Reasoning Series: A 70-Year-Old Man With Systemic Illness Related Strokes Refractory to Medical Treatment Managed With Intracranial Stent

97

Epstein-Barr Virus Antibodies to Differentiate MS From Other Neuroinflammatory Diseases - Part 1

98

Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 1

99

April 20, 2026 Capitol Hill Report: Neuroscience Research in FY2027

100

Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 1

101

Monogenic Mimics of Neuroinflammatory Phenotypes in Children and Young Adults - Part 2

102

Neurotoxicity Imaging in Children and Young Adults After CAR T-Cell Therapy for B-Cell Malignancies

103

Measles - Part 3

104

Medical Student Perspectives on Stigma in FND

105

Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes

106

The Best of Headache Medicine from 2024: A Year in Review

107

Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 2

108

Neurology on the Hill

109

Blood Biomarkers to Detect Alzheimer Disease - Part 1

110

Physician as Patient Series - Multiple Sclerosis

111

Multiple Sclerosis and Family Planning

112

Incorporating Genetic Testing Into the Care of Patients with ALS/FTD

113

Careers in Neurology: Clinical Trialist

114

Drug Pricing Update Part 1

115

The future of hospital systems & healthcare